HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferreira, R. Articles by Boveris, A. Search for Related Content PubMed PubMed Citation Articles by Ferreira, R. Articles by Boveris, A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 100, 708-714, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium

R Ferreira, M Burgos, J Milei, S Llesuy, L Molteni, H Hourquebie and A Boveris
Department of Cardiovascular Service (ECAVI), Policlinico Bancario, Buenos Aires, Argentina.

Fourteen randomized patients undergoing myocardial revascularization were divided into group A standard hypothermic cardioplegic solution) and group B (the same cardioplegic solution supplemented with deferoxamine 1000 mg/L). In all patients myocardial biopsy specimens were obtained before ischemia and during reperfusion and were assessed for chemiluminescence (to indirectly determine oxygen-free radical activity) and for electron microscopic studies. Chemiluminescence in group A showed a photoemission of 36.5 +/- 1.5 cpm/mg protein X10(-3) for the preischemia samples and 72 +/- 5.7 cpm/mg protein X10(-3) for the reperfusion samples (p less than 0.01). In the patients who received deferoxime (group B), values for chemiluminescence for preischemia and reperfusion samples were not significantly different. Electron microscopic studies showed a significant increase in grade 4 (severely damaged) mitochondria in reperfusion biopsy specimens from both groups as compared with preischemia samples. However, reperfusion samples from group B showed a better preservation of myocardial cells with marked reduction of grade 4 (severely damaged) mitochondria. These results support the hypothesis that oxygen-free radicals are responsible in part for the production of reperfusion injury in the human heart. They suggest that this mechanism may be at least partially controlled by adding an iron chelating agent such as deferoxime.

This article has been cited by other articles:

				J. Milei, P. Forcada, C. G. Fraga, D. R. Grana, G. Iannelli, M. Chiariello, I. Tritto, and G. Ambrosio Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion Cardiovasc Res, March 1, 2007; 73(4): 710 - 719. [Abstract] [Full Text] [PDF]

				L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF]

				I. A. Paraskevaidis, E. K. Iliodromitis, D. Vlahakos, D. P. Tsiapras, A. Nikolaidis, A. Marathias, A. Michalis, and D. Th. Kremastinos Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance Eur. Heart J., February 1, 2005; 26(3): 263 - 270. [Abstract] [Full Text] [PDF]

				J. Milei, C. G. Fraga, D. R. Grana, R. Ferreira, and G. Ambrosio Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2329 - 2336. [Abstract] [Full Text] [PDF]

				S. M. Weman, P. J. Karhunen, A. Penttila, A. A. Jarvinen, and U.-S. Salminen Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting Ann. Thorac. Surg., September 1, 2000; 70(3): 807 - 812. [Abstract] [Full Text] [PDF]

				A T. Ulus, P. Gokce, E. Ozgencil, U. Yildiz, E. Ibrisim, and S F. Katircioglu Beneficial Effects of Aminophylline on Ischemia-Reperfusion in Isolated Rabbit Heart Asian Cardiovasc Thorac Ann, June 1, 1999; 7(2): 96 - 100. [Abstract] [Full Text] [PDF]

				S. C. Nicholson, M. Squier, D. J. P. Ferguson, Z. Nagy, S. Westaby, and R. D. Evans Effect of Desferrioxamine Cardioplegia on Ischemia-Reperfusion Injury in Isolated Rat Heart Ann. Thorac. Surg., April 1, 1997; 63(4): 1003 - 1011. [Abstract] [Full Text]

				G. Drossos, A. Lazou, P. Panagopoulos, and S. Westaby Deferoxamine Cardioplegia Reduces Superoxide Radical Production in Human Myocardium Ann. Thorac. Surg., January 1, 1995; 59(1): 169 - 172. [Abstract] [Full Text]

				J. G. Coghlan, W. D. Flitter, S. M. Clutton, R. Panda, R. Daly, G. Wright, C. D. Ilsley, and T. F. Slater Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 248 - 256. [Abstract] [Full Text]